跳转至内容
Merck
CN

主要文件

查看所有文档

UFC30GV0S

Ultrafree®离心过滤管，样品体积0.5 mL

pore size 0.22 μm, PVDF membrane (hydrophilic)

别名:

Centrifuge filter

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

UNSPSC Code:
41104916
NACRES:
NB.24
eCl@ss:
36100101
Material:
PVDF membrane (hydrophilic), polypropylene
Pore size:
0.22 μm pore size
Working volume:
0.5 mL
Sterility:
sterile
Packaging:
pkg of 50 ea
技术服务
需要帮助？我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

Quality Level

400

material

PVDF membrane (hydrophilic), polypropylene

sterility

sterile

feature

holdup volume 5 μL

packaging

pkg of 50 ea

manufacturer/tradename

Ultrafree®

parameter

0.5 mL sample volume, 50 °C max. temp.

technique(s)

protein extraction: suitable, protein purification: suitable

L

45 mm

diam.

10.6 mm

filtration area

0.2 cm2

working volume

0.5 mL

matrix

Durapore®

pore size

0.22 μm pore size

application(s)

sample preparation

shipped in

ambient

General description

Ultrafree®-MC (0.5 mL)和Ultrafree®-CL (2 mL)离心过滤管（超滤管）是用于去除生物水溶液中颗粒的一次性过滤器。这款过滤管有两种处理体积和一系列微孔滤膜（从0.1至5.0µm），过滤速度快，再现性好。还提供已预先灭菌的过滤器。适用定角转子，1.5 mL（-MC）和 15 mL（–CL）离心管。

滤器编码：GVPP
滤器类型：微滤

Application

Ultrafree®-MC GV离心过滤器已被用于：


  • 离心后过滤用于无标记质谱的细胞裂解液
  • 过滤缓冲液中萃取的酶以制备用于细胞直接随机光学重构显微镜学（dSTORM）和基于DNA的点累积纳米形貌成像（DNA-PAINT）的成像溶液
  • 在转染研究中纯化病毒溶液
  • 过滤用于制备高压液相色谱（HPLC）分析用样品的心组织匀浆液

Features and Benefits

  • 用于去除水性和一些溶剂基样品中的颗粒和沉淀物
  • 特别适用于蛋白质和核酸溶液。

  • 用于去除水溶液样品或某些溶剂样品中的颗粒和沉淀物
  • 适用于处理蛋白和核酸溶液

Physical form

色码：黄色

Legal Information

Durapore is a registered trademark of Merck KGaA, Darmstadt, Germany
Ultrafree is a registered trademark of Merck KGaA, Darmstadt, Germany

Still not finding the right product?

Explore all of our products under Ultrafree®离心过滤管，样品体积0.5 mL

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

实验方案

Affinity Purification with Ultrafree®-MC Centrifugal Filters

Affinity interaction chromatography is an effective method for protein purification that can achieve up to 95% purity in one step

Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome.
Agar, Cetin, et al.
Blood, 116, 1336-1343 (2010)
Cetin Agar et al.
Blood, 117(25), 6939-6947 (2011-04-02)
Sepsis is a systemic host response to invasive infection by bacteria. Despite treatment with antibiotics, current mortality rates are in the range of 20%-25%, which makes sepsis the most important cause of death in intensive care. Gram-negative bacteria are a

全球贸易项目编号

货号GTIN
UFC30GV0S04053252577512